Gualtierotti, Roberta https://orcid.org/0000-0001-6465-7624
Bressi, Cinzia
Garavaglia, Barbara
Brambilla, Paolo
Funding for this research was provided by:
Ministero della Salute (Ricerca Corrente)
Article History
Received: 15 July 2024
Accepted: 2 October 2024
First Online: 23 October 2024
Declarations
:
: Roberta Gualtierotti is on the advisory boards of Bayer, Roche, Sanofi, SOBI, and Novo Nordisk, and has participated in speaker bureau/educational meetings for Pfizer, SOBI, Takeda, and Novo Nordisk. Cinzia Bressi, Barbara Garavaglia and Paolo Brambilla have nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.